William D. Humphries
CIK 1674278 · President, Ortho-Dermatologics · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.30M
Companies
5
Total Filings
48
Lifetime Open-Market Net
-$2.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Director | 45,105 | $5.33 | $240.4K | $0 | 13 | 2026-06-08 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | 3,403 | $0.35 | $1.2K | $9.9K | 12 | 2024-06-21 |
| STRATA Skin Sciences, Inc. (SSKN) Delisted | Director | 10,972 | $0.15 | $1.6K | $52.8K | 5 | 2023-07-07 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | — | $0.07 | — | $0 | 3 | 2022-06-10 |
| BHC | President, Ortho-Dermatologics | 235,035 | $4.52 | $1.06M | -$2.43M | 11 | 2020-12-08 |
Recent Filings · Page 3 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-11 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | ACRS | Grant (A) | — | $0 | EDGAR |
| 2020-12-08 | BHC | Mixed | — | -$626.3K | EDGAR |
| 2020-11-30 | BHC | Mixed | — | -$193.3K | EDGAR |
| 2020-09-10 | BHC | Sell (S) | −5,667 | -$91.6K | EDGAR |
| 2020-08-19 | BHC | Tax (F) | −4,567 | -$79.8K | EDGAR |
| 2020-08-18 | Clearside Biomedical, Inc. (CLSD) Delisted | Buy (P) | +5,586 | $9.9K | EDGAR |
| 2020-06-19 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | ACRS | Mixed | +7,333 | $0 | EDGAR |
| 2020-03-04 | ACRS | Mixed | +8,876 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.